
Global Maternal Pertussis Vaccine for Newborn Protection Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global Maternal Pertussis Vaccine for Newborn Protection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include Zhifei Biological, Walvax, Minhai Biological, GlaxoSmithKline, Sanofi Pasteur and Intravacc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Maternal Pertussis Vaccine for Newborn Protection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Maternal Pertussis Vaccine for Newborn Protection, also provides the sales of main regions and countries. Of the upcoming market potential for Maternal Pertussis Vaccine for Newborn Protection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Maternal Pertussis Vaccine for Newborn Protection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Maternal Pertussis Vaccine for Newborn Protection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Maternal Pertussis Vaccine for Newborn Protection sales, projected growth trends, production technology, application and end-user industry.
Maternal Pertussis Vaccine for Newborn Protection Segment by Company
Zhifei Biological
Walvax
Minhai Biological
GlaxoSmithKline
Sanofi Pasteur
Intravacc
Maternal Pertussis Vaccine for Newborn Protection Segment by Type
Whole-cell Pertussis Vaccine
Acellular Pertussis Vaccine
Maternal Pertussis Vaccine for Newborn Protection Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Maternal Pertussis Vaccine for Newborn Protection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Pertussis Vaccine for Newborn Protection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Pertussis Vaccine for Newborn Protection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Maternal Pertussis Vaccine for Newborn Protection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Maternal Pertussis Vaccine for Newborn Protection sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Maternal Pertussis Vaccine for Newborn Protection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include Zhifei Biological, Walvax, Minhai Biological, GlaxoSmithKline, Sanofi Pasteur and Intravacc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Maternal Pertussis Vaccine for Newborn Protection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Maternal Pertussis Vaccine for Newborn Protection, also provides the sales of main regions and countries. Of the upcoming market potential for Maternal Pertussis Vaccine for Newborn Protection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Maternal Pertussis Vaccine for Newborn Protection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Maternal Pertussis Vaccine for Newborn Protection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Maternal Pertussis Vaccine for Newborn Protection sales, projected growth trends, production technology, application and end-user industry.
Maternal Pertussis Vaccine for Newborn Protection Segment by Company
Zhifei Biological
Walvax
Minhai Biological
GlaxoSmithKline
Sanofi Pasteur
Intravacc
Maternal Pertussis Vaccine for Newborn Protection Segment by Type
Whole-cell Pertussis Vaccine
Acellular Pertussis Vaccine
Maternal Pertussis Vaccine for Newborn Protection Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Maternal Pertussis Vaccine for Newborn Protection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Pertussis Vaccine for Newborn Protection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Pertussis Vaccine for Newborn Protection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Maternal Pertussis Vaccine for Newborn Protection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Maternal Pertussis Vaccine for Newborn Protection sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
199 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Maternal Pertussis Vaccine for Newborn Protection Market by Type
- 1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 Whole-cell Pertussis Vaccine
- 1.2.3 Acellular Pertussis Vaccine
- 1.3 Maternal Pertussis Vaccine for Newborn Protection Market by Application
- 1.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Hospital
- 1.3.3 Centers for Disease Control and Prevention
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Maternal Pertussis Vaccine for Newborn Protection Market Dynamics
- 2.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
- 2.2 Maternal Pertussis Vaccine for Newborn Protection Industry Drivers
- 2.3 Maternal Pertussis Vaccine for Newborn Protection Industry Opportunities and Challenges
- 2.4 Maternal Pertussis Vaccine for Newborn Protection Industry Restraints
- 3 Global Market Growth Prospects
- 3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Estimates and Forecasts (2020-2031)
- 3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region
- 3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2020-2025)
- 3.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2026-2031)
- 3.2.4 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2031)
- 3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Estimates and Forecasts 2020-2031
- 3.4 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region
- 3.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2020 VS 2024 VS 2031
- 3.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025)
- 3.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2026-2031)
- 3.4.4 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2031)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
- 4 Market Competitive Landscape by Manufacturers
- 4.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Manufacturers
- 4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Manufacturers (2020-2025)
- 4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2020-2025)
- 4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Manufacturers
- 4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Manufacturers (2020-2025)
- 4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2020-2025)
- 4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Sales Share Top 10 and Top 5 in 2024
- 4.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Price by Manufacturers (2020-2025)
- 4.4 Global Maternal Pertussis Vaccine for Newborn Protection Key Manufacturers Ranking, 2023 VS 2024 VS 2025
- 4.5 Global Maternal Pertussis Vaccine for Newborn Protection Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers, Product Type & Application
- 4.7 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market CR5 and HHI
- 4.8.2 2024 Maternal Pertussis Vaccine for Newborn Protection Tier 1, Tier 2, and Tier 3
- 5 Maternal Pertussis Vaccine for Newborn Protection Market by Type
- 5.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type
- 5.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020 VS 2024 VS 2031)
- 5.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031) & (US$ Million)
- 5.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2020-2031)
- 5.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type
- 5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020 VS 2024 VS 2031)
- 5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031) & (Units)
- 5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2031)
- 5.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type
- 6 Maternal Pertussis Vaccine for Newborn Protection Market by Application
- 6.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application
- 6.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020 VS 2024 VS 2031)
- 6.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031) & (US$ Million)
- 6.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2020-2031)
- 6.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application
- 6.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020 VS 2024 VS 2031)
- 6.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031) & (Units)
- 6.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2031)
- 6.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application
- 7 Company Profiles
- 7.1 Zhifei Biological
- 7.1.1 Zhifei Biological Comapny Information
- 7.1.2 Zhifei Biological Business Overview
- 7.1.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 7.1.5 Zhifei Biological Recent Developments
- 7.2 Walvax
- 7.2.1 Walvax Comapny Information
- 7.2.2 Walvax Business Overview
- 7.2.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 7.2.5 Walvax Recent Developments
- 7.3 Minhai Biological
- 7.3.1 Minhai Biological Comapny Information
- 7.3.2 Minhai Biological Business Overview
- 7.3.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 7.3.5 Minhai Biological Recent Developments
- 7.4 GlaxoSmithKline
- 7.4.1 GlaxoSmithKline Comapny Information
- 7.4.2 GlaxoSmithKline Business Overview
- 7.4.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 7.4.5 GlaxoSmithKline Recent Developments
- 7.5 Sanofi Pasteur
- 7.5.1 Sanofi Pasteur Comapny Information
- 7.5.2 Sanofi Pasteur Business Overview
- 7.5.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 7.5.5 Sanofi Pasteur Recent Developments
- 7.6 Intravacc
- 7.6.1 Intravacc Comapny Information
- 7.6.2 Intravacc Business Overview
- 7.6.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 7.6.5 Intravacc Recent Developments
- 8 North America
- 8.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
- 8.1.1 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031)
- 8.1.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031)
- 8.1.3 North America Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2031)
- 8.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
- 8.2.1 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031)
- 8.2.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031)
- 8.2.3 North America Maternal Pertussis Vaccine for Newborn Protection Price by Application (2020-2031)
- 8.3 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 8.3.1 North America Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 8.3.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020 VS 2024 VS 2031)
- 8.3.3 North America Maternal Pertussis Vaccine for Newborn Protection Price by Country (2020-2031)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
- 9 Europe
- 9.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
- 9.1.1 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031)
- 9.1.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031)
- 9.1.3 Europe Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2031)
- 9.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
- 9.2.1 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031)
- 9.2.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031)
- 9.2.3 Europe Maternal Pertussis Vaccine for Newborn Protection Price by Application (2020-2031)
- 9.3 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 9.3.1 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 9.3.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020 VS 2024 VS 2031)
- 9.3.3 Europe Maternal Pertussis Vaccine for Newborn Protection Price by Country (2020-2031)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
- 10 China
- 10.1 China Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
- 10.1.1 China Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031)
- 10.1.2 China Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031)
- 10.1.3 China Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2031)
- 10.2 China Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
- 10.2.1 China Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031)
- 10.2.2 China Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031)
- 10.2.3 China Maternal Pertussis Vaccine for Newborn Protection Price by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
- 11.1.1 Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031)
- 11.1.2 Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031)
- 11.1.3 Asia Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2031)
- 11.2 Asia Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
- 11.2.1 Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031)
- 11.2.2 Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031)
- 11.2.3 Asia Maternal Pertussis Vaccine for Newborn Protection Price by Application (2020-2031)
- 11.3 Asia Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 11.3.1 Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 11.3.2 Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020 VS 2024 VS 2031)
- 11.3.3 Asia Maternal Pertussis Vaccine for Newborn Protection Price by Country (2020-2031)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
- 12.1.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031)
- 12.1.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031)
- 12.1.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2031)
- 12.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
- 12.2.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031)
- 12.2.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031)
- 12.2.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Price by Application (2020-2031)
- 12.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 12.3.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 12.3.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020 VS 2024 VS 2031)
- 12.3.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Price by Country (2020-2031)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
- 13 Value Chain and Sales Channels Analysis
- 13.1 Maternal Pertussis Vaccine for Newborn Protection Value Chain Analysis
- 13.1.1 Maternal Pertussis Vaccine for Newborn Protection Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process
- 13.2 Maternal Pertussis Vaccine for Newborn Protection Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
- 13.2.3 Maternal Pertussis Vaccine for Newborn Protection Customers
- 14 Concluding Insights
- 15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.